{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:20:04Z","timestamp":1782966004294,"version":"3.54.5"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PSG819"],"award-info":[{"award-number":["PSG819"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cca.2025.120271","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T20:54:25Z","timestamp":1743713665000},"page":"120271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Vascular calcification inhibitors in chronic kidney disease"],"prefix":"10.1016","volume":"572","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9263-8014","authenticated-orcid":false,"given":"Annika","family":"Adoberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisi","family":"Leis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merike","family":"Luman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Uhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Fridolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margus","family":"Viigimaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Holmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cca.2025.120271_b0005","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/ATVBAHA.113.302249","article-title":"Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2","volume":"33","author":"Crouthamel","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.bbrc.2014.08.007","article-title":"Microtubule stabilization attenuates vascular calcification through the inhibition of osteogenic signaling and matrix vesicle release","volume":"451","author":"Lee","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2025.120271_b0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2019.09.068","article-title":"High-phosphate induced vascular calcification is reduced by iron citrate through inhibition of extracellular matrix osteo-chondrogenic shift in VSMCs","volume":"297","author":"Ciceri","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cca.2025.120271_b0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yjmcc.2019.12.006","article-title":"Oxidative stress contributes to vascular calcification in patients with chronic kidney disease","volume":"138","author":"Huang","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0025","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/ijms20030628","article-title":"Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review","volume":"20","author":"Roumeliotis","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0030","first-page":"111","article-title":"Vascular Calcification: A Passive Process That Requires Active Inhibition","volume":"13","author":"Villa-Bellosta","year":"2024","journal-title":"Biology (Basel)"},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0035","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00223-020-00783-3","article-title":"Secreted phosphoprotein 24 is a biomarker of mineral metabolism","volume":"108","author":"Turner","year":"2021","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/00365513.2019.1576218","article-title":"Long-term follow-up of biomarkers of vascular calcification after switch from traditional hemodialysis to online hemodiafiltration","volume":"79","author":"Uhlin","year":"2019","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"4","key":"10.1016\/j.cca.2025.120271_b0045","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00223-012-9690-6","article-title":"The role of fetuin-A in physiological and pathological mineralization","volume":"93","author":"Brylka","year":"2013","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cyto.2008.08.014","article-title":"Serum fetuin-A concentrations are inversely related to cytokine concentrations in patients with chronic renal failure","volume":"44","author":"Dervisoglu","year":"2008","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.cca.2025.120271_b0055","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ki.2008.700","article-title":"Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure","volume":"75","author":"Matsui","year":"2009","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.cca.2025.120271_b0060","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/ndt\/gfk045","article-title":"Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis","volume":"21","author":"Herman","year":"2006","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2265.2006.02716.x","article-title":"Association of serum fetuin-A with carotid arterial stiffness","volume":"66","author":"Mori","year":"2007","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.cca.2025.120271_b0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.17219\/acem\/82517","article-title":"The importance of fetuin-A in vascular calcification in children with chronic kidney disease","volume":"28","author":"Makulska","year":"2019","journal-title":"Adv. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0075","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1080\/0886022X.2021.1969248","article-title":"The relationship between calcification inhibitor levels in chronic kidney disease and the development of atherosclerosis","volume":"43","author":"Sevinc","year":"2021","journal-title":"Ren. Fail."},{"key":"10.1016\/j.cca.2025.120271_b0080","unstructured":"H.M Okuyan, O. \u00d6zcan, S. Do\u011fan, A. Arpac\u0131, F.H. Turgut Upper Zone of Growth Plate and Cartilage Matrix Associated (UCMA) Levels in Patients with Chronic Kidney Disease. Brazilian Archives of Biology and Technology. 10.1590\/1678-4324-2020190594."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010805","article-title":"Risk factors associated with altered circulating MicroRNA-125b and their influences on uremic vascular calcification among patients with end-stage renal disease","volume":"8","author":"Chao","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0090","first-page":"327","article-title":"Serum fetuin-A is associated with the components of MIAC(malnutrition, inflammation, atherosclerosis, calcification) syndrome in different stages of chronic kidney disease, Turk","volume":"49","author":"Mutluay","year":"2019","journal-title":"J. Med. Sci."},{"issue":"6","key":"10.1016\/j.cca.2025.120271_b0095","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/ndt\/gfp723","article-title":"Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4","volume":"25","author":"Ford","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"8","key":"10.1016\/j.cca.2025.120271_b0100","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/diagnostics14080824","article-title":"Comparative analysis of vascular calcification risk factors in pre-hemodialysis and prevalent hemodialysis adult patients: insights into calcification biomarker associations and implications for intervention strategies in chronic kidney disease","volume":"14","author":"Petrovi\u0107","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.cca.2025.120271_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-14-122","article-title":"Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients","author":"Pateinakis","year":"2013","journal-title":"BMC Nephrol."},{"issue":"4","key":"10.1016\/j.cca.2025.120271_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae065","article-title":"Associations of urinary fetuin-A with histopathology and kidney events in biopsy-proven kidney disease","volume":"17","author":"Tsai","year":"2024","journal-title":"Clin. Kidney J."},{"issue":"6","key":"10.1016\/j.cca.2025.120271_b0115","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1681\/ASN.2008060572","article-title":"Fetuin-A protects against atherosclerotic calcification in CKD","volume":"20","author":"Westenfeld","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.cca.2025.120271_b0120","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1681\/ASN.2009090944","article-title":"Fetuin-mineral complex reflects extraosseous calcification stress in CKD","volume":"21","author":"Hamano","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.cca.2025.120271_b0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ki.2010.194","article-title":"FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease","volume":"78","author":"Yilmaz","year":"2010","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.cca.2025.120271_b0130","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","article-title":"Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD","volume":"27","author":"Smith","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"19","key":"10.1016\/j.cca.2025.120271_b0135","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/CIRCULATIONAHA.106.682450","article-title":"Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the heart and soul study","volume":"115","author":"Ix","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/ATVBAHA.117.310578","article-title":"Chronic kidney disease circulating calciprotein particles and extracellular vesicles promote vascular calcification: a role for GRP (Gla-Rich Protein)","volume":"38","author":"Viegas","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120271_b0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jsbmb.2010.03.064","article-title":"Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality","volume":"121","author":"Dusso","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"8","key":"10.1016\/j.cca.2025.120271_b0150","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1681\/ASN.2007080902","article-title":"Vitamin D receptor activators can protect against vascular calcification","volume":"19","author":"Mathew","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2025.120271_b0155","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/ndt\/gfr758","article-title":"Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-\u03b1","volume":"27","author":"Aoshima","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2025.120271_b0160","unstructured":"W.M. Murray SL, Calcium and Phosphate Disorders: Core Curriculum 2024, Am J Kidney Dis Dec 13:S0272-6386(23)00772-2 (2023)."},{"issue":"12","key":"10.1016\/j.cca.2025.120271_b0165","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ki.2009.83","article-title":"Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin","volume":"75","author":"El-Abbadi","year":"2009","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.cca.2025.120271_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/nu15061470","article-title":"Serum and Urinary soluble \u03b1-klotho as markers of kidney and vascular impairment","volume":"15","author":"Mart\u00edn-V\u00edrgala","year":"2023","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.cca.2025.120271_b0175","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.3390\/ijms25094875","article-title":"Non-Classical Effects of FGF23: Molecular and Clinical Features","volume":"25","author":"Mart\u00ednez-Heredia","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120271_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-14-39","article-title":"Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study","volume":"14","author":"Yasin","year":"2013","journal-title":"BMC Nephrol."},{"issue":"5","key":"10.1016\/j.cca.2025.120271_b0185","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","article-title":"Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency","volume":"85","author":"Jimbo","year":"2014","journal-title":"Kidney Int."},{"issue":"18","key":"10.1016\/j.cca.2025.120271_b0190","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cca.2025.120271_b0195","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/kjm2.12072","article-title":"Klotho\/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b\/\u03b2-catenin pathway","volume":"35","author":"Chen","year":"2019","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0200","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.kint.2015.12.029","article-title":"Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of \u03b1-Klotho","volume":"89","author":"Chang","year":"2016","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.cca.2025.120271_b0205","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.kint.2015.12.046","article-title":"Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification","volume":"89","author":"Paloian","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2025.120271_b0210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2016.08.010","article-title":"Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells","volume":"253","author":"Nakahara","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2025.120271_b0215","doi-asserted-by":"crossref","unstructured":"N.S. Roy ME, Matrix Gla protein binding to hydroxyapatite depends on the ionic environment: calcium enhances binding affinity, but phosphate and magnesium decrease affinity, 31:296\u2013302. (2002).","DOI":"10.1016\/S8756-3282(02)00821-9"},{"issue":"4","key":"10.1016\/j.cca.2025.120271_b0220","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2215\/CJN.07081009","article-title":"The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report","volume":"5","author":"Schurgers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.cca.2025.120271_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/nu9121334","article-title":"Prevalence and effects of functional vitamin K insufficiency: the PREVEND study","volume":"9","author":"Riphagen","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.cca.2025.120271_b0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2840-13-85","article-title":"Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein","volume":"13","author":"Liabeuf","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"issue":"7","key":"10.1016\/j.cca.2025.120271_b0235","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/ndt\/gfp024","article-title":"Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study","volume":"24","author":"Parker","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"9","key":"10.1016\/j.cca.2025.120271_b0240","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/ajh\/hpy079","article-title":"Circulating dephospho-uncarboxylated matrix gla-protein is associated with kidney dysfunction and arterial stiffness","volume":"31","author":"Puzantian","year":"2018","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2025.120271_b0245","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.2147\/IJGM.S331758","article-title":"The relationship between carotid intima media thickness inflammation and GLA rich protein levels in chronic kidney disease","volume":"14","author":"Demirci","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0250","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","article-title":"Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial","volume":"59","author":"Westenfeld","year":"2012","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0255","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ajcn\/nqab375","article-title":"Vitamin K status, all-cause mortality, and cardiovascular disease in adults with chronic kidney disease: the chronic renal insufficiency cohort","volume":"115","author":"Shea","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0260","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ndt\/gfac191","article-title":"Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial","volume":"38","author":"Holden","year":"2023","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0265","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.2013.530","article-title":"Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation","volume":"86","author":"Kaesler","year":"2014","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0270","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.clnu.2016.04.024","article-title":"Low vitamin K1 intake in haemodialysis patients","volume":"36","author":"Fusaro","year":"2017","journal-title":"Clin. Nutr."},{"issue":"9","key":"10.1016\/j.cca.2025.120271_b0275","doi-asserted-by":"crossref","first-page":"917","DOI":"10.5551\/jat.23218","article-title":"Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification","volume":"21","author":"Iijima","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"issue":"6","key":"10.1016\/j.cca.2025.120271_b0280","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajh\/hpy049","article-title":"Inactive matrix gla protein, arterial stiffness, and endothelial function in african american hemodialysis patients","volume":"31","author":"Fain","year":"2018","journal-title":"Am. J. Hypertens."},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120271_b0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11010-017-3023-z","article-title":"Vitamin K2 inhibits rat vascular smooth muscle cell calcification by restoring the Gas6\/Axl\/Akt anti-apoptotic pathway","volume":"433","author":"Qiu","year":"2017","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0290","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/07853890.2012.727019","article-title":"The role of osteoprotegerin in cardiovascular disease","volume":"45","author":"Montagnana","year":"2013","journal-title":"Annals of medicine"},{"key":"10.1016\/j.cca.2025.120271_b0295","doi-asserted-by":"crossref","first-page":"814970","DOI":"10.3389\/fmed.2022.814970","article-title":"Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients","volume":"9","author":"Okasha","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.cca.2025.120271_b0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2018.01.011","article-title":"M, Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease","volume":"270","author":"Bozic","year":"2018","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0305","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ndt\/gfr321","article-title":"Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner","volume":"27","author":"Kircelli","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0310","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1515\/CCLM.2009.075","article-title":"Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease","volume":"47","author":"Mesquita","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"10.1016\/j.cca.2025.120271_b0315","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/tri.13847","article-title":"Association between serum osteoprotegerin level and mortality in kidney transplant recipients: a prospective observational cohort study","volume":"34","author":"Gupta","year":"2021","journal-title":"Transpl. Int."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0320","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2006.08.052","article-title":"Association of high alpha2-Heremans-Schmid glycoprotein\/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass","volume":"195","author":"Fiore","year":"2007","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0325","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/s41598-018-20241-3","article-title":"Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation","volume":"8","author":"Ter Braake","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cca.2025.120271_b0330","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1161\/ATVBAHA.117.309182","article-title":"Magnesium Counteracts Vascular Calcification: Passive Interference or Active Modulation?","volume":"37","author":"Ter Braake","year":"2017","journal-title":"Arterioscler. Thromb. Vascular Biol."},{"issue":"5","key":"10.1016\/j.cca.2025.120271_b0335","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ndt\/gfz190","article-title":"Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification","volume":"35","author":"Ter Braake","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0340","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000334742","article-title":"Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification","volume":"35","author":"Salem","year":"2012","journal-title":"Am. J. Nephrol."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0345","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3892\/etm.2015.2215","article-title":"Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time-dependent manner","volume":"9","author":"Xu","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0350","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/s13063-022-06562-9","volume":"23","author":"Vermeulen","year":"2022","journal-title":"Trials"},{"issue":"6","key":"10.1016\/j.cca.2025.120271_b0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253592","article-title":"Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5","volume":"16","author":"Ito","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cca.2025.120271_b0360","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1681\/ASN.0000000000000092","article-title":"The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD),J","volume":"34","author":"Bressendorff","year":"2023","journal-title":"Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.cca.2025.120271_b0365","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/ndt\/gfs520","article-title":"Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells","volume":"28","author":"Louvet","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0370","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/20905068.2019.1592930","article-title":"Serum sclerostin as a potential biomarker of vascular and valvular types of calcification in chronic kidney disease cases with and without maintenance hemodialysis","volume":"55","author":"Moghazy","year":"2019","journal-title":"Alexandria J. Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120271_b0375","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jbmr.4503","article-title":"Sclerostin protects against vascular calcification development in mice","volume":"37","author":"De Mar\u00e9","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nefro.2015.07.006","article-title":"Serum sclerostin levels, arteriovenous fistula calcification and 2-years all-cause mortality in prevalent hemodialysis patients","volume":"36","author":"Kirkpantur","year":"2016","journal-title":"Nefrologia"},{"issue":"11\u201312","key":"10.1016\/j.cca.2025.120271_b0385","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1159\/000528795","article-title":"Serum sclerostin levels and mortality in hemodialysis patients: an 8-year prospective study","volume":"53","author":"Nakagawa","year":"2022","journal-title":"Am. J. Nephrol."},{"issue":"12","key":"10.1016\/j.cca.2025.120271_b0390","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/gft039","article-title":"Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?","volume":"28","author":"Viaene","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.cca.2025.120271_b0395","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif. Tissue Int."},{"issue":"12","key":"10.1016\/j.cca.2025.120271_b0400","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11255-016-1379-8","article-title":"Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4","volume":"48","author":"Lv","year":"2016","journal-title":"Int. Urol. Nephrol."},{"issue":"8","key":"10.1016\/j.cca.2025.120271_b0405","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ndt\/gfv081","article-title":"Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications","volume":"30","author":"Morena","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0410","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cyto.2008.08.014","article-title":"Serum fetuin\u2013a concentrations are inversely related to cytokine concentrations in patients with chronic renal failure","volume":"44","author":"Dervisoglu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2025.120271_b0415","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4324-2020190594","article-title":"Upper zone of growth plate and cartilage matrix (UCMA) levels in patients with chronic kidney disease","volume":"63","author":"Okuyan","year":"2020","journal-title":"Braz. Arch. Biol. Technol."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0420","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010805","article-title":"Risk factors associated with altered circulating micro RNA -125b and their influences on uremic vascular calcification among patients with end-stage renal disease","volume":"8","author":"Chao","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0425","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3906\/sag-1809-43","article-title":"Serum fetuin-A is associated with the components of MIAC (malnutrition, inflammation, atherosclerosis, calcification) syndrome in different stages of chronic kidney disease","volume":"49","author":"Mutluay","year":"2019","journal-title":"Turkish J. Med. Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0430","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12882-024-03876-5","article-title":"PIVKA-II but not dp-ucMGP is associated with aortic calcification in chronic kidney disease","volume":"25","author":"Nyvad","year":"2024","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1016\/j.cca.2025.120271_b0435","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1210\/jc.2013-1521","article-title":"Sclerostin: another vascular calcification inhibitor?","volume":"98","author":"Claes","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056695","article-title":"A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease","volume":"8","author":"Kitagawa","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cca.2025.120271_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036175","article-title":"Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients","volume":"7","author":"Morena","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0450","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000453368","article-title":"Correlations of plasma desphosphorylated uncarboxylated matrix gla protein with vascular calcification and vascular stiffness in chronic kidney disease","volume":"135","author":"Thamratnopkoon","year":"2017","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0455","doi-asserted-by":"crossref","first-page":"431","DOI":"10.21037\/jtd.2020.01.49","article-title":"Calcification of coronary arteries and aortic valve and circulating a-klotho levels in patients with chronic kidney disease","volume":"12","author":"Savvoulidis","year":"2020","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"10.1016\/j.cca.2025.120271_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/nu15061470","article-title":"Serum and Urinary Soluble alpha-Klotho as Markers of Kidney and Vascular Impairment","volume":"15","author":"Martin-Virgala","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0465","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000334742","article-title":"Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification","volume":"35","author":"Salem","year":"2012","journal-title":"Am. J. Nephrol."},{"issue":"9","key":"10.1016\/j.cca.2025.120271_b0470","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1210\/jc.2012-1811","article-title":"Biological variability of plasma intact and C-terminal FGF23 measurements","volume":"97","author":"Smith","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0475","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ndt\/gfr316","article-title":"FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4 another link between chronic kidney disease-mineral bone disorder and the heart","volume":"27","author":"Ford","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0480","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12882-024-03771-z","article-title":"Carotid intima-media thickness, fibroblast growth factor 23, and mineral bone disorder in children with chronic kidney disease","volume":"25","author":"Palupi-Baroto","year":"2024","journal-title":"BMC Nephrol"},{"issue":"11","key":"10.1016\/j.cca.2025.120271_b0485","first-page":"781","article-title":"Proteoglycan\/glycosaminoglycan and collagen content in the arterial wall of patients with end-stage renal disease: new indicators of vascular disease","volume":"129","author":"Batko","year":"2019","journal-title":"Pol. Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0490","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030635","article-title":"Gla-Rich Protein (GRP) as an early and novel marker of vascular calcification and kidney dysfunction in diabetic patients with CKD: a pilot cross-sectional study","volume":"9","author":"Silva","year":"2020","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.cca.2025.120271_b0495","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1002\/jbmr.2907","article-title":"Low dentin matrix protein 1 is associated with incident cardiovascular events in peritoneal dialysis patients","volume":"31","author":"Yoon","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cca.2025.120271_b0500","article-title":"Association of serum osteoprotegerin level with myocardial injury and cardiovascular calcification in chronic kidney disease patients","volume":"9","author":"Okasha","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"issue":"8","key":"10.1016\/j.cca.2025.120271_b0505","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/00365510701432509","article-title":"Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein","volume":"67","author":"Sennels","year":"2007","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"3","key":"10.1016\/j.cca.2025.120271_b0510","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ekir.2017.12.001","article-title":"Benefit of Apabetalone on Plasma Proteins in Renal Disease","volume":"3","author":"Wasiak","year":"2017","journal-title":"Kidney Int. Rep."},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0515","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000488257","article-title":"Apabetalone mediated epigenetic modulation is associated with favorable kidney function and alkaline phosphatase profile in patients with chronic kidney disease","volume":"43","author":"Kulikowski","year":"2018","journal-title":"Kidney Blood Press. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0520","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00018-024-05486-8","article-title":"Dapagliflozin targets SGLT2\/SIRT1 signaling to attenuate the osteogenic transdifferentiation of vascular smooth muscle cells","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci: CMLS"},{"issue":"13","key":"10.1016\/j.cca.2025.120271_b0525","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/cvr\/cvad119","article-title":"Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome","volume":"119","author":"Chen","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cca.2025.120271_b0530","doi-asserted-by":"crossref","first-page":"103183","DOI":"10.1016\/j.redox.2024.103183","article-title":"Sodium-glucose cotransporter 2 inhibitors attenuate vascular calcification by suppressing endoplasmic reticulum protein thioredoxin domain containing 5 dependent osteogenic reprogramming","volume":"73","author":"Wu","year":"2024","journal-title":"Redox. Biol."},{"key":"10.1016\/j.cca.2025.120271_b0535","doi-asserted-by":"crossref","unstructured":"K. Ng, C.M. Hildreth, A.P. Avolio, J.K. Phillips, J. K. Angiotensin-converting enzyme inhibitor limits pulse-wave velocity and aortic calcification in a rat model of cystic renal disease. American J. Physiol. Renal Physiol., (2011) 301(5), F959\u2013F966.","DOI":"10.1152\/ajprenal.00393.2011"},{"issue":"3-4","key":"10.1016\/j.cca.2025.120271_b0540","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000452411","article-title":"Long-term angiotensin II receptor blockade limits hypertension, aortic dysfunction, and structural remodeling in a rat model of chronic kidney disease","volume":"53","author":"Ameer OZ","year":"2016","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.cca.2025.120271_b0545","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbrc.2021.10.023","article-title":"Protective effects of spironolactone on vascular calcification in chronic kidney disease","volume":"582","author":"Hammer","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2025.120271_b0550","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijcard.2018.11.119","article-title":"Cardiac valve calcification and use of anticoagulants: preliminary observation of a potentially modifiable risk factor","volume":"278","author":"Di Lullo","year":"2019","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.cca.2025.120271_b0555","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1681\/ASN.2008070788","article-title":"Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells","volume":"20","author":"Zarjou","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2025.120271_b0560","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2016.09.071","article-title":"Iron citrate reduces high phosphate-induced vascular calcification by inhibiting apoptosis","volume":"254","author":"Ciceri","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2025.120271_b0565","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/cbin.11811","article-title":"Lanthanum hydroxide inhibits vascular calcification by regulating the HIF-1 pathway","volume":"46","author":"Wang","year":"2022","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.cca.2025.120271_b0570","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3389\/fphys.2019.01584","article-title":"Zinc Inhibits HIF-prolyl hydroxylase inhibitor-aggravated VSMC calcification induced by high phosphate","volume":"10","author":"Nagy","year":"2019","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0575","doi-asserted-by":"crossref","first-page":"17810","DOI":"10.1038\/s41598-019-54306-8","article-title":"Barley-\u00df-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase 2 inhibition","volume":"9","author":"Arcidiacono","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120271_b0580","doi-asserted-by":"crossref","unstructured":"W. Jiang, W. Ruan, Z. Wang, Z. Dendrobium officinale polysaccharide inhibits vascular calcification via anti-inflammatory and anti-apoptotic effects in chronic kidney disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, (2022) 36(9), e22504.","DOI":"10.1096\/fj.202200353RRR"},{"key":"10.1016\/j.cca.2025.120271_b0585","doi-asserted-by":"crossref","first-page":"121460","DOI":"10.1016\/j.lfs.2023.121460","article-title":"Soluble guanylate cyclase agonist, isoliquiritigenin attenuates renal damage and aortic calcification in a rat model of chronic kidney failure","volume":"317","author":"Atteia","year":"2023","journal-title":"Life sciences"},{"issue":"19","key":"10.1016\/j.cca.2025.120271_b0590","doi-asserted-by":"crossref","first-page":"18775","DOI":"10.1021\/acsnano.3c03041","article-title":"A bioactive disintegrable polymer nanoparticle for synergistic vascular anticalcification","volume":"17","author":"Adelnia","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0595","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00395-021-00899-z","article-title":"Prevention of vascular calcification by the endogenous chromogranin A-derived mediator that inhibits osteogenic transdifferentiation","volume":"116","author":"Orth-Alampour","year":"2021","journal-title":"Basic Res. Cardiol."},{"issue":"10","key":"10.1016\/j.cca.2025.120271_b0600","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00109-024-02468-y","article-title":"Oral pyrophosphate protects Abcc6-\/- mice against vascular calcification induced by chronic kidney disease","volume":"102","author":"Bouderlique","year":"2024","journal-title":"J. Mol. Med. (Berlin, Germany)"},{"issue":"7","key":"10.1016\/j.cca.2025.120271_b0605","doi-asserted-by":"crossref","first-page":"123","DOI":"10.14715\/cmb\/2022.68.7.20","article-title":"Mechanisms of miR-29a-5p involvement in osteogenic phenotype transformation and cellular regulation of vascular smooth muscle and thus influencing calcification in VSMCs in chronic kidney disease","volume":"68","author":"Deng","year":"2022","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand)"},{"issue":"21","key":"10.1016\/j.cca.2025.120271_b0610","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1042\/CS20210259","article-title":"Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling","volume":"135","author":"Feng","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.cca.2025.120271_b0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196232","article-title":"FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K\/Akt signaling and inhibiting apoptosis","volume":"13","author":"Ponnusamy","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cca.2025.120271_b0620","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/path.5334","article-title":"CDC42 promotes vascular calcification in chronic kidney disease","volume":"249","author":"Li","year":"2019","journal-title":"J. Pathol."},{"issue":"24","key":"10.1016\/j.cca.2025.120271_b0625","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1016\/j.bmc.2013.09.053","article-title":"Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests","volume":"21","author":"Debray","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cca.2025.120271_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115392","article-title":"Pharmacological TNAP inhibition efficiently inhibits arterial media calcification in a warfarin rat model but deserves careful consideration of potential physiological bone formation\/mineralization impairment","volume":"137","author":"Opdebeeck","year":"2020","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.cca.2025.120271_b0635","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/jbmr.1733","article-title":"Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification","volume":"28","author":"Kiffer-Moreira","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.cca.2025.120271_b0640","article-title":"Significance of acPWV for survival of hemodialysis patients","volume":"56","author":"Petrovic","year":"2020","journal-title":"Medicina-Lithuania"},{"issue":"2","key":"10.1016\/j.cca.2025.120271_b0645","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12020496","article-title":"Gla-rich protein, magnesium and phosphate associate with mitral and aortic valves calcification in diabetic patients with moderate CKD","volume":"12","author":"Silva","year":"2022","journal-title":"Diagnostics"},{"issue":"6","key":"10.1016\/j.cca.2025.120271_b0650","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajh\/hpy049","article-title":"Inactive matrix gla protein, arterial stiffness, and endothelia function in african american hemodialysis patients","volume":"31","author":"Fain","year":"2018","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2025.120271_b0655","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11517-023-02992-y","article-title":"Effect of transmural pressure on the estimation of arterial stiffness index from the photoplethysmographic waveform","volume":"62","author":"Pilt","year":"2024","journal-title":"Med. Biol. Eng. Comput."},{"issue":"24","key":"10.1016\/j.cca.2025.120271_b0660","doi-asserted-by":"crossref","first-page":"9882","DOI":"10.3390\/s23249882","article-title":"Photoplethysmography for the Assessment of Arterial Stiffness","volume":"23","author":"Karimpour","year":"2023","journal-title":"Sensors (Basel, Switzerland)"},{"key":"10.1016\/j.cca.2025.120271_b0665","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41598-024-51395-y","article-title":"Arterial stiffness assessment using PPG feature extraction and significance testing in an in vitro cardiovascular system","volume":"14","author":"Ferizoli","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120271_b0670","doi-asserted-by":"crossref","unstructured":"K. Lauri, J. Arund, J. Holmar, R. Tanner, S. Kalle, M. Luman, I. Fridolin, IRemoval of Urea, \u03b22-Microglobulin, and Indoxyl Sulfate Assessed by Absorbance and Fluorescence in the Spent Dialysate During Hemodialysis. ASAIO Journal (American Society for Artificial Internal Organs : 1992), (2020) 66(6), 698\u2013705.","DOI":"10.1097\/MAT.0000000000001058"},{"key":"10.1016\/j.cca.2025.120271_b0675","doi-asserted-by":"crossref","unstructured":"J. Holmar, F. Uhlin, A. Fernstr\u00f6m, M. Luman, J. Jankowski, I. Fridolin, I. An optical method for serum calcium and phosphorus level assessment during hemodialysis. Toxins, (2015) 7(3), 719\u2013727.","DOI":"10.3390\/toxins7030719"},{"key":"10.1016\/j.cca.2025.120271_b0680","doi-asserted-by":"crossref","unstructured":"A. Lindgren, E. Fjellstedt, A. Christensson, A. Comparison of Hemodialysis Using a Medium Cutoff Dialyzer versus Hemodiafiltration: A Controlled Cross-Over Study. International journal of nephrology and renovascular disease, (2020)13, 273\u2013280.","DOI":"10.2147\/IJNRD.S263110"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:36:27Z","timestamp":1778646987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":136,"alternative-id":["S0009898125001500"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120271","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular calcification inhibitors in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120271"}}